Implanet has been granted US Food and Drug Administration 510k clearance and CE marking in Europe to market its new Jazz Lock implant.
Jazz Lock is the first of a range of band products designed for degenerative spine disorder surgery. Based on the polyester sublaminar braid platform, Jazz Lock is designed to eliminate the mechanism’s locking screw and connecting rod, thanks to a proprietary fastening locking system. Implanet should thus offer surgeons a new implant with an optimised and reproducible surgical technique, according to a company release.
Régis Le Couedic, Implanet’s Product Development & Manufacturing director, says, “Over the last two years, we have focused our efforts on finalising our range of Jazz Band implants, notably with the…range of connectors, to ensure compatibility with all existing posterior fixation systems.”